ATX-101 Abdominoplasty

Phase 1CompletedNCT00835952

Kythera Biopharmaceuticals14 enrolled

Overview

Histopathological study of abdominal fat excised from subjects undergoing abdominoplasty

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

NONE

Enrollment

ATX-101 single doses

Sex: ALLMin age: 25 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy subjects undergoing planned abdominoplasty Exclusion Criteria: * History of interventions in the abdominal area

Unnamed facility

San Francisco, California, United States

Unnamed facility

Santa Monica, California, United States

Adverse events, laboratory test results, physical examinations

Time frame: 1 - 28 days

Histopathology

Time frame: 1 - 28 Days

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.